List of works - Laura Richert

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design

scientific article published on 26 February 2014

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

scientific article published in PLoS ONE

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

scientific article

ChatGPT and beyond with artificial intelligence (AI) in health: Lessons to be learned

scientific article published in 2023

Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers

scientific article published in June 2013

Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity

scientific article published on 27 March 2015

Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load

scientific article published on September 2014

Diabetes and cognitive decline in a French cohort of patients infected with HIV-1.

scientific article

Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy

scientific article

Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination

article

Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals

article

Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints?

scientific article

Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field

scientific article published on February 2010

No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults

scientific article

Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells.

scientific article published on 11 November 2016

Recent developments in clinical trial designs for HIV vaccine research

scientific article

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.

scientific article published on August 2017

T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial

scientific article published in 2022

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques

scientific article

List of works by Laura Richert

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

ChatGPT and beyond with artificial intelligence (AI) in health: Lessons to be learned

Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers

Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity

Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load

Diabetes and cognitive decline in a French cohort of patients infected with HIV-1.

Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy

Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination

Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals

Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints?

Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field

No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults

Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells.

Recent developments in clinical trial designs for HIV vaccine research

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.

T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques